- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- S-4 Registration of securities issued in business combination transactions
- 3.3 EX-3.3
- 3.4 EX-3.4
- 3.5 EX-3.5
- 3.6 EX-3.6
- 3.7 EX-3.7
- 3.8 EX-3.8
- 3.9 EX-3.9
- 3.10 EX-3.10
- 3.11 EX-3.11
- 3.12 EX-3.12
- 3.13 EX-3.13
- 3.14 EX-3.14
- 3.15 EX-3.15
- 3.16 EX-3.16
- 3.17 EX-3.17
- 3.18 EX-3.18
- 3.19 EX-3.19
- 3.20 EX-3.20
- 3.21 EX-3.21
- 3.22 EX-3.22
- 3.23 EX-3.23
- 3.24 EX-3.24
- 3.25 EX-3.25
- 3.26 EX-3.26
- 3.27 EX-3.27
- 3.28 EX-3.28
- 3.29 EX-3.29
- 3.30 EX-3.30
- 3.31 EX-3.31
- 3.32 EX-3.32
- 3.33 EX-3.33
- 3.34 EX-3.34
- 3.35 EX-3.35
- 3.36 EX-3.36
- 3.37 EX-3.37
- 3.38 EX-3.38
- 3.39 EX-3.39
- 3.40 EX-3.40
- 3.41 EX-3.41
- 3.42 EX-3.42
- 3.43 EX-3.43
- 3.44 EX-3.44
- 3.45 EX-3.45
- 3.46 EX-3.46
- 3.47 EX-3.47
- 3.48 EX-3.48
- 3.49 EX-3.49
- 3.50 EX-3.50
- 3.51 EX-3.51
- 3.52 EX-3.52
- 3.53 EX-3.53
- 3.54 EX-3.54
- 3.55 EX-3.55
- 3.56 EX-3.56
- 3.57 EX-3.57
- 3.58 EX-3.58
- 3.59 EX-3.59
- 3.60 EX-3.60
- 3.61 EX-3.61
- 3.62 EX-3.62
- 3.63 EX-3.63
- 3.64 EX-3.64
- 3.65 EX-3.65
- 3.66 EX-3.66
- 3.67 EX-3.67
- 3.68 EX-3.68
- 3.69 EX-3.69
- 3.70 EX-3.70
- 3.71 EX-3.71
- 3.72 EX-3.72
- 4.8 EX-4.8
- 4.9 EX-4.9
- 5.1 EX-5.1
- 5.2 EX-5.2
- 5.3 EX-5.3
- 10.1 EX-10.1
- 10.2 EX-10.2
- 22.1 EX-22.1
- 23.1 EX-23.1
- 25.1 EX-25.1
- 99.1 EX-99.1
- 99.2 EX-99.2
- EX-FILING FEES Ex-filing Fees
- 25 Jan 24 424B3 Prospectus supplement
- 23 Jan 24 EFFECT Notice of effectiveness
- 18 Jan 24 S-4/A Registration of securities issued in business combination transactions (amended)
-
5 Jan 24 S-4 Registration of securities issued in business combination transactions
Exhibit 107
Calculation of Filing Fee Tables
Form S-4
(Form Type)
IQVIA Holdings Inc.
IQVIA Inc.
Benefit Holding, Inc.
BuzzeoPDMA LLC
Data Niche Associates, Inc.
IMS Software Services Ltd.
Innovex Merger Corp.
Intercontinental Medical Statistics International, Ltd.
IQVIA BioSciences Holdings, LLC
IQVIA Biotech LLC (f/k/a Novella Clinical LLC)
IQVIA Chinametrik Inc.
IQVIA Commercial Finance Inc.
IQVIA Commercial India Holdings Corp.
IQVIA Commercial Trading Corp.
IQVIA CSMS US Inc.
IQVIA Government Solutions Inc.
IQVIA Medical Communications & Consulting, Inc.
IQVIA Medical Education Inc.
IQVIA Pharma Inc.
IQVIA Pharma Services Corp.
IQVIA Phase One Services LLC
IQVIA RDS Asia Inc.
IQVIA RDS Inc.
IQVIA RDS Latin America LLC
IQVIA Trading Management Inc.
IQVIA Transportation Services Corp.
Med-Vantage, Inc.
Outcome Sciences, LLC
Q Squared Solutions Holdings LLC
Q Squared Solutions LLC
QCare Site Services, Inc.
RX India, LLC
Targeted Molecular Diagnostics, LLC
ValueMedics Research, LLC
VCG&A, Inc.
VCG-BIO, INC.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type | Security Title | Fee Rule or | Amount Registered | Proposed Maximum Price per | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial Effective Date | Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward | |||||||||||||
Newly Registered Securities | ||||||||||||||||||||||||
Fees to Be Paid | Debt | 5.700% Senior Secured Notes due 2028 | 457(f) | $750,000,000 | 100% | $750,000,000 (2) | 0.00014760 | $110,700 | ||||||||||||||||
Debt | 6.250% Senior Secured Notes due 2029 | 457(f) | $1,250,000,000 | 100% | $1,250,000,000 (3) | 0.00014760 | $184,500 | |||||||||||||||||
Fees Previously Paid | — | — | — | — | — | — | — | |||||||||||||||||
Carry Forward Securities | ||||||||||||||||||||||||
Carry Forward Securities | — | — | — | — | — | — | — | — | — | |||||||||||||||
Total Offering Amounts | $2,000,000,000 | $295,200 | ||||||||||||||||||||||
Total Fees Previously Paid | — | |||||||||||||||||||||||
Total Fee Offsets | — | |||||||||||||||||||||||
Net Fee Due | $295,200 |
(1) | Calculated pursuant to Rule 457(f) under the Securities Act of 1933, as amended. |
(2) | Represents the aggregate principal amount of IQVIA Inc.’s 5.700% Senior Secured Notes due 2028 to be offered in the exchange offer to which the registration statement relates. |
(3) | Represents the aggregate principal amount of IQVIA Inc.’s 6.250% Senior Secured Notes due 2029 to be offered in the exchange offer to which the registration statement relates. |